arrow
P

Pattraporn Tajarernmuang

Chiang Mai University
H指数:12
被引数:537

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative Carcinogenic Risk Assessment of Polycyclic Aromatic Hydrocarbons Accumulation in Normal and Cancerous Lung Tissues of Patients from Northern Thailand

比较泰国北部患者正常和癌变肺组织中多环芳烃积累的致癌风险评估

Toxics
IF4.1
2026-08-200
OA
Effects of Fine Particulate Matter on Systemic Inflammatory Biomarkers in Elderly Patients with Chronic Obstructive Pulmonary Disease Versus the Healthy Elderly: A Pilot Study

细颗粒物对慢性阻塞性肺疾病老年患者系统性炎症生物标志物的影响与对健康老年人的比较:一项初步研究

2026-08-120
OA
Risk-adapted venous thromboembolism prophylaxis in Asian patients admitted to medical intensive care unit: a prospective controlled trial

亚洲入住内科重症监护室患者的风险适应性静脉血栓栓塞症预防:一项前瞻性对照试验

2025-11-060
OAAI
Low-dose intradermal mRNA-1273 boosting vaccine following BBiBP-CorV vaccination during the omicron pandemics

奥密克戎疫情期间,在接种BBiBP-CorV疫苗后使用低剂量皮内mRNA-1273加强疫苗

Vaccine
IF3.5
2025-07-080
PRE
The National Early Warning Score 2 with Age and Body Mass Index (NEWS2 Plus) to Determine Patients with Severe COVID-19 Pneumonia
2024-01-046
OAAI
Validation of the Pulmonary Embolism Severity Index Risk Classification and the 2019 European Society of Cardiology Risk Stratification in the Southeast Asian Population with Acute Pulmonary Embolism
2023-11-014
OAAI
Levels and durability of neutralizing antibodies against SARS-CoV-2 Omicron and other variants after ChAdOx-1 or BNT162b2 booster in CoronaVac-primed elderly individuals

CoronaVac引发的老年人ChAdOx-1或BNT162b2助推器后针对SARS-CoV-2 Omicron和其他变体的中和抗体的水平和持久性

HELIYON
IF3.6
2023-04-011
OAAI
Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study
2022-12-182
OAAI
Clinical Characteristics, Risk Factors, and Outcomes of Acute Pulmonary Embolism in Asian Population
2022-11-253
OAAI
Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination

疫苗接种后Anti-SARS-CoV-2 RBD IgG与抗SARS-CoV-2 Omicron变体中和抗体的相关性分析

2022-05-2521
OAAI
Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine

在先前用CoronaVac疫苗免疫的老年人中,ChAdOx-1或BNT162b2增强后针对SARS-CoV-2相关变体的中和抗体和T细胞反应

2022-05-249
OAAI